Table IV.
Univariate and multivariate analyses of clinical characteristics in patients with hepatocellular carcinoma.
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| Variables | HR | 95% CI | P-value | HR | 95% CI | P-value |
| Sex | ||||||
| Female | – | – | – | |||
| Male | 1.054 | 0.446–2.493 | 0.904 | |||
| Recurrence | ||||||
| Negative | – | – | – | |||
| Positive | 0.043 | 0.000–13.801 | 0.285 | |||
| Clinical stage | ||||||
| Stage I, II | – | – | – | – | – | – |
| Stage III, IV | 3.487 | 1.465–8.302 | 0.005 | 3.255 | 1.365–7.762 | 0.008 |
| Differentiation | ||||||
| Well or moderate | – | – | – | |||
| Poor | 1.734 | 0.815–3.690 | 0.153 | |||
| EpCAM | ||||||
| Low | – | – | – | – | – | – |
| High | 2.238 | 1.004–4.989 | 0.049 | 2.108 | 0.943–4.712 | 0.069 |
HR, hazard ratio; CI, confidence interval; EpCAM, epithelial cell adhesion molecule.